Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP3550 (Degarelix) Maintenance Dose Finding in Prostate Cancer
NCT01261572Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2010
- Primary completion
- Apr 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of degarelix in prostate cancer (PCa), sponsored by Astellas Pharma. Started Oct 2010; status: completed.
02
Drugs
degarelix
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01261572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01261572.